← All trials
NCT02547103
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2016
- Primary completion
- Jun 30, 2021
- Completion date
- Aug 31, 2021
- First posted
- Sep 11, 2015
- Last posted
- Jul 29, 2019
- Enrollment
- 354
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Chiangmai UniversityLead sponsor
- Chiangmai UniversityReponsible party - principal investigator
- Chiangmai UniversityStudy director
- Chiangmai UniversityOfficial
- Chiangmai UniversitySponsor investigator
- Health Systems Research Institute, ThailandCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.